Increased risk for other cancers in individuals with Ewing sarcoma and their relatives
- PMID: 31670911
- PMCID: PMC6912049
- DOI: 10.1002/cam4.2575
Increased risk for other cancers in individuals with Ewing sarcoma and their relatives
Abstract
Background: There are few reports of the association of other cancers with Ewing sarcoma in patients and their relatives. We use a resource combining statewide genealogy and cancer reporting to provide unbiased risks.
Methods: Using a combined genealogy of 2.3 million Utah individuals and the Utah Cancer Registry (UCR), relative risks (RRs) for cancers of other sites were estimated in 143 Ewing sarcoma patients using a Cox proportional hazards model with matched controls; however, risks in relatives were estimated using internal cohort-specific cancer rates in first-, second-, and third-degree relatives.
Results: Cancers of three sites (breast, brain, complex genotype/karyotype sarcoma) were observed in excess in Ewing sarcoma patients. No Ewing sarcoma patients were identified among first-, second-, or third-degree relatives of Ewing sarcoma patients. Significantly increased risk for brain, lung/bronchus, female genital, and prostate cancer was observed in first-degree relatives. Significantly increased risks were observed in second-degree relatives for breast cancer, nonmelanoma eye cancer, malignant peripheral nerve sheath cancer, non-Hodgkin lymphoma, and translocation sarcomas. Significantly increased risks for stomach cancer, prostate cancer, and acute lymphocytic leukemia were observed in third-degree relatives.
Conclusions: This analysis of risk for cancer among Ewing sarcoma patients and their relatives indicates evidence for some increased cancer predisposition in this population which can be used to individualize consideration of potential treatment of patients and screening of patients and relatives.
Keywords: Ewing sarcoma; UPDB; cancer; relative; relative risk.
© 2019 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors have no conflict of interest with the information presented.
References
-
- Sorensen PH, Lessnick SL, Lopez‐Terrada D, Liu XF, Triche TJ, Denny CT. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS‐family transcription factor, ERG. Nat Gen. 1994;6:146‐151. - PubMed
-
- Peter M, Couturier J, Pacquement H, et al. A new member of the ETS family fused to EWS in Ewing tumors. Oncogene. 1997;14:1159‐1164. - PubMed
-
- Jeon IS, Davis JN, Braun BS, et al. A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. Oncogene. 1995;10:1229‐1234. - PubMed
-
- Delattre O, Zucman J, Plougastel B, et al. Gene fusion with an ETS DNA‐binding domain caused by chromosome translocation in human tumours. Nature. 1992;359:162‐165. - PubMed
-
- Jawad MU, Cheung MC, Min ES, Schneiderbauer MM, Koniaris LG, Scully SP. Ewing sarcoma demonstrates racial disparities in incidence‐related and sex‐related differences in outcome: an analysis of 1631 cases from the SEER database, 1973–2005. Cancer. 2009;115:3526‐3536. - PubMed
